The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer-related activity has suffered. Find out all about it in the comprehensive report of Whole Genome Sequencing. The complete genome of the COVID virus is included as an example of the work being done.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What’s holding the industry back? Where are the over 800 locations that have high throughput devices?
Our facts and support = Your success.
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players is racing for market share on a truly global stage.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
This research will make you the expert in your organization. Get the research team working for you by ordering all, or a portion, of this comprehensive report. All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
The report includes five-year market forecasts and detailed breakouts for 14 countries and 5 regions.
1 Market Guides
1.1 Whole Genome Sequencing Market - Strategic Situation Analysis & COVID Impact
1.1.1 Selected Genetic Testing Companies Revenue & Growth
1.1.2 Selected Companies Growth Chart
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2. Introduction and Market Definition
2.1 Whole Genome Sequencing Definition In This Report
2.1.1 Whole and Exome Sequencing
2.1.2 Research and Clinical
2.1.3 Clinical Tumor
2.1.4 Clinical Pathogen
2.1.6 Direct to Consumer
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
2.4.1 Global Healthcare Spending
2.4.2 Spending on Diagnostics
2.4.3 Important Role of Insurance for Diagnostics
2.5 Sizing the Genome - Not What You Think
2.5.1 Cost, Price and Genome Size, Pricing Practice
2.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts
3 Market Overview
3.1 Market Participants Play Different Roles
3.1.2 Independent lab specialized/esoteric
3.1.3 Independent lab national/regional
3.1.4 Independent lab analytical
3.1.5 Public National/regional lab
3.1.6 Hospital lab
3.1.7 Physician lab
3.1.8 DTC Lab
3.1.9 Sequencing Labs
3.1.10 Audit body
3.2 Whole Genome Sequencing - Markets, Examples and Discussion
3.2.1 Direct to Consumer - Two Approaches
220.127.116.11 The New Age of Medical Information
18.104.22.168 Dangers in DTC-WGS - Health Costs and Regulation
22.214.171.124 Newborn and Prenatal - A Brave New World
126.96.36.199 DTC - How Many Segments?
3.2.2 Research Markets
188.8.131.52 Research Funding and Capital Expense
184.108.40.206 WGS Datasets Preferred
220.127.116.11 Existing research repurposed
18.104.22.168 Organism Wide Market
22.214.171.124 Service Suppliers Respond
3.2.3 Clinical - Understanding Germline and Somatic
126.96.36.199 Somatic - Chasing Mutations and Pharmacogenomics
3.2.4 Pathogen Testing
188.8.131.52 The Hepatitis C Story
184.108.40.206 Will the Microbiology Department Disappear?
3.2.5 AgriBio - Big Business
220.127.116.11 GMO is Here to Stay
18.104.22.168 WGS Benefits and Risks
22.214.171.124 The New Agriculture
3.3 Industry Structure
3.3.1 Hospital’s Testing Share
3.3.2 Economies of Scale
3.3.3 Instrument Manufacturer Role
3.3.4 Healthcare Industry Impacts - Still Struggling
126.96.36.199 Can the Healthcare Industry Adapt?
188.8.131.52 Genetic Counselling as an Industry
184.108.40.206 WGES Adoption and Cannibalization
220.127.116.11 The Meaning of Grail
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Diagnostic Factors
4.1.2 Interpreting the Code Otherwise
4.1.3 Changes in Agriculture
4.1.4 Fertility Technology Comes of Age
4.1.5 Pathogen Challenges
4.2 Factors Limiting Growth
4.2.1 Increased Competition Lowers Price
4.2.2 Lower Costs
4.2.3 Healthcare Cost Concerns Curtail Growth
4.2.4 Wellness has a downside
4.2.5 GMO Opposition Movement
4.3 Sequencing Instrumentation
4.3.1 Instrumentation Tenacity
4.3.2 Declining Cost Changes Industry Structure
4.3.3 LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS
4.3.6 Pacific Biosystems
4.3.7 Roche 454
4.3.9 Oxford Nanopore
18.104.22.168 What is Oxford Nanopore Sequencing?
22.214.171.124 What can Oxford Nanopore Sequencingt be used for?
126.96.36.199 Oxford Nanopore Products
4.3.10 Long Reads - Further Segmentation
4.3.11 Linked Reads
4.3.12 Targeted Sequencing Adopts CRISPR
4.3.13 New Sequencing Technologies
188.8.131.52 RNAP sequencing
184.108.40.206 In vitro virus high-throughput sequencing
220.127.116.11 Tunnelling currents DNA sequencing
18.104.22.168 Sequencing by hybridization
22.214.171.124 Sequencing with mass spectrometry
126.96.36.199 Microfluidic Sanger sequencing
188.8.131.52 Microscopy-based techniques
5 WGES Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 GenomSys Gains CE Mark for New Genomic Analysis Software
5.3 WGS Finds Lung Cancers Fall Into Molecular Subtypes
5.4 Testing Distinguishes Benign Tumors From Precancerous Condition
5.5 Plan to Sequence All Newborns in UK
5.6 Clear Labs Raises $60M for Nanopore Sequencing
5.7 Variantyx Expands Into Prenatal, Cancer Testing
5.8 Whole-Genome Sequencing Aids Diagnosis in Stockholm
5.9 Variantyx Raises $20M
5.10 Nonacus WGS Service for SARS-CoV-2 Laboratories
5.11 Center to Report Risk Scores in Clinical WGS
5.12 Stanford Launches WGS for Cardiovascular Testing
5.13 Illumina and NY Healthcare Partner on Clinical WGS
5.14 Increased Adoption of WGS Needs Acceptance by Payors, Providers
5.15 Veritas Intercontinental Completes €5M Series B Financing Round
5.16 M2GEN and Discovery Life Sciences in Bioinformatics Agreement
5.17 Genomics England Adopts Quantum ActiveScale Object Storage
5.18 GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx
5.19 NHS Wales Introduces WGS for Critically Ill Newborns
5.20 Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test
5.21 C2i Genomics to Launch Trials for MRD Detection Tech
5.22 Roche Acquires Sequencing Company Stratos Genomics
5.23 UK COVID-19 Sequencing Consortium Launches
5.24 Invitae Acquires Three Companies: YouScript, Genelex, Diploid
5.25 Experience From Centralized Genomic Medicine Lab
5.26 MGI to Enable $100 Human Genome
5.27 Nebula Genomics offers $299 WGS
5.28 Team to Study Campylobacter Omics
5.29 Veritas Genetics Restarts US Business
5.30 NEOGEN, Gencove partner to advance animal genomics
5.31 UK Whole-Genome Sequencing Project Obtains £200M
5.32 WGS may help with disease outbreaks
5.33 Veritas Cuts WGS Price by 40%
5.34 Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
5.35 Machine-learning system used to diagnose genetic diseases
5.36 Whole Genome Sequencing for healthy creates controversy
5.37 Nebula Genomics Offers FREE Whole Genome Sequencing
6 Profiles of Key Companies
6.1 10x Genomics, Inc.
6.2 23andME Inc.
6.3 Abbott Diagnostics
6.4 AccuraGen Inc.
6.5 Adaptive Biotechnologies
6.6 Admera Health, LLC
6.7 Agena Bioscience, Inc.
6.9 Akonni Biosystems
6.10 Ancestry.com LLC
6.11 Anchor Dx
6.12 ArcherDx, Inc.
6.13 ARUP Laboratories
6.15 Baylor Miraca Genetics Laboratories
6.16 Beckman Coulter Diagnostics
6.17 Becton, Dickinson and Company
6.18 BGI Genomics Co. Ltd
6.19 Bioarray Genetics
6.20 Biocept, Inc.
6.21 Biodesix Inc.
6.24 Biolidics Ltd
6.25 bioMérieux Diagnostics
6.26 Bioneer Corporation
6.27 Bio-Rad Laboratories, Inc
6.29 C2i Genomics
6.30 Cancer Genetics
6.31 Caris Molecular Diagnostics
6.32 CellMax Life
6.34 Chronix Biomedical
6.36 Clear Labs
6.37 Clinical Genomics
6.38 Complete Genomics, Inc. - A BGI Company
6.40 Dante Labs
6.41 Datar Cancer Genetics Limited
6.42 Day Zero Diagnostics
6.43 Diasorin S.p.A.
6.44 Epic Sciences
6.45 Epigenomics AG.
6.46 Eurofins Scientific
6.47 Excellerate Bioscience
6.48 Exosome Diagnostics
6.49 Fabric Genomics
6.50 Fluidigm Corp
6.52 FUJIFILM Wako Diagnostics
6.54 Fulgent Genetics
6.55 GE Global Research
6.56 GE Healthcare Life Sciences
6.59 GeneFirst Ltd.
6.60 Genetron Health (Beijing) Co., Ltd.
6.62 Genomic Health
6.63 Genomics England
6.64 Genomics Personalized Health (GPH)
6.66 Genzyme Corporation
6.67 Grail, Inc.
6.69 Guardant Health
6.75 Horizon Discovery
6.76 HTG Molecular Diagnostics
6.77 Human Longevity, Inc.
6.80 Incell Dx
6.82 Invitae Corporation
6.86 MDNA Life SCIENCES, Inc.
6.87 MDx Health
6.89 Meridian Bioscience
6.90 Mesa Biotech
6.92 miR Scientific
6.93 MNG Labs
6.94 Molecular MD
6.95 NantHealth, Inc.
6.97 Nebula Genomics
6.99 New Oncology
6.100 Novogene Bioinformatics Technology Co., Ltd.
6.101 Omega Bioservices
6.104 ORIG3N, Inc.
6.105 Origene Technologies
6.106 Oxford Nanopore Technologies
6.108 Perkin Elmer
6.109 Personal Genome Diagnostics
6.114 Protagen Diagnostics
6.115 Qiagen Gmbh
6.118 Roche Molecular Diagnostics
6.119 Roswell Biotechnologies
6.122 Siemens Healthineers
6.123 simfo GmbH
6.124 Singlera Genomics Inc.
6.126 Stratos Genomics
6.127 Sure Genomics, Inc.
6.129 Sysmex Inostics
6.130 Tempus Labs, Inc.
6.131 Thermo Fisher Scientific Inc.
6.132 Veritas Genetics
7 The Global Market for Whole Genome Sequencing
7.1 Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country
7.2 Global Market by Application - Overview
7.2.1 Table - Global Market by Application
7.2.2 Chart - Global Market by Application - Base/Final Year Comparison
7.2.3 Chart - Global Market by Application - Base Year
7.2.4 Chart - Global Market by Application - Final Year
7.2.5 Chart - Global Market by Application - Share by Year
7.2.6 Chart - Global Market by Application - Segment Growth
7.3 Global Market by Organism - Overview
7.3.1 Table - Global Market by Organism
7.3.2 Chart - Global Market by Organism - Base/Final Year Comparison
7.3.3 Chart - Global Market by Organism - Base Year
7.3.4 Chart - Global Market by Organism - Final Year
7.3.5 Chart - Global Market by Organism - Share by Year
7.3.6 Chart - Global Market by Organism - Segment Growth
7.4 Global Market by Product - Overview
7.4.1 Table - Global Market by Product
7.4.2 Chart - Global Market by Product - Base/Final Year Comparison
7.4.3 Chart - Global Market by Product - Base Year
7.4.4 Chart - Global Market by Product - Final Year
7.4.5 Chart - Global Market by Product - Share by Year
7.4.6 Chart - Global Market by Product - Segment Growth
8 Global Whole Genome Sequencing Markets - by Application
8.1.1 Table Research - by Country
8.1.2 Chart - Research Growth
8.2 Clinical Human
8.2.1 Table Clinical Human - by Country
8.2.2 Chart - Clinical Human Growth
8.3 Clinical Tumor
8.3.1 Table Clinical Tumor - by Country
8.3.2 Chart - Clinical Tumor Growth
8.4 Clinical Pathogen
8.4.1 Table Clinical Pathogen - by Country
8.4.2 Chart - Clinical Pathogen Growth
8.5 Direct to Consumer
8.5.1 Table Direct to Consumer - by Country
8.5.2 Chart - Direct to Consumer Growth
8.6.1 Table Agriculture/Other - by Country
8.6.2 Chart - Agriculture/Other Growth
9 Global Whole Genome Sequencing Markets - by Organism
9.1.1 Table Human - by Country
9.1.2 Chart - Human Growth
9.2.1 Table Pathogen - by Country
9.2.2 Chart - Pathogen Growth
9.3 Other Organism
9.3.1 Table Other Organism - by Country
9.3.2 Chart - Other Organism Growth
10 Global Whole Genome Sequencing Markets - by Product
10.1.1 Table Instruments - by Country
10.1.2 Chart - Instruments Growth
10.2.1 Table Reagents - by Country
10.2.2 Chart - Reagent Growth
10.3.1 Table Analysis - by Country
10.3.2 Chart - Analysis Growth
10.4 Software & Other
10.4.1 Table Software & Other - by Country
10.4.2 Chart - Software & Other Growth
11 Vision of the Future of Whole Genome Sequencing
12.1 United States Medicare System: January 2021 laboratory Fees Schedule
12.2 The Whole Genome Sequence of SARS-CoV-2
Table of Tables
Table 1 Leading Genomic Companies Revenue Growth (USD $M)
Table 2 The Base Pairs
Table 3 Most Common Traditional Genetic Disorders
Table 4 List of GLOBAL SEQUENCING LOCATIONS
Table 5 Market Players by Type
Table 6 The Different Markets for Whole Genome Sequencing
Table 7 DTC Sub Segments
Table 8 Roles of WGS in AgriBio
Table 9 The Factors Driving Growth
Table 10 Factors Limiting Growth
Table 11 - Listing of Current NGS Instrument Specifications
Table 12 Six New Sequencing Technologies
Table 13 - Global Market by Region
Table 14 Global Market by Application
Table 15 Global Market by Organism
Table 16 Global Market by Product
Table 17 Research by Country
Table 18 Clinical Human by Country
Table 19 Clinical Tumor by Country..
Table 20 Clinical Pathogen by Country
Table 21 Direct to Consumer by Country
Table 22 Agriculture/Other by Country
Table 23 Human by Country
Table 24 Pathogen by Country
Table 25 Other Organism by Country
Table 26 Instruments by Country
Table 27 Reagents by Country
Table 28 Analysis by Country
Table 29 Software & Other by Country
Table 30 2021 Clinical Lab Fee Schedule
Table of Figures
Figure 1 Relative Growth of Select Genomic Companies
Figure 2 Size of Genome for Various Species
Figure 3 Cost To Sequence a Human Genome
Figure 4 Base Year Country Market Share Chart
Figure 5 Global Market by Application - Base vs. Final Year
Figure 6 Global Market by Application Base Year
Figure 7 Global Market by Application Final Year
Figure 8 Application Type Share by Year.
Figure 9 by Application Segment Growth
Figure 10 by Organism - Base vs. Final Year
Figure 11 by Organism Market Base Year
Figure 12 by Organism Market Final Year
Figure 13 by Organism Share by Year
Figure 14 by Organism Segment Growth
Figure 15 by Product - Base vs. Final Year
Figure 16 by Product Market Base Year
Figure 17 by Product Market Final Year
Figure 18 by Product Share by Year
Figure 19 by Product Segment Growth
Figure 20 Research Growth
Figure 21 Clinical Human Growth
Figure 22 Clinical Tumor Growth
Figure 23 Clinical Pathogen Growth
Figure 24 Direct to Consumer Growth
Figure 25 Agriculture/Other Growth
Figure 26 Human Growth
Figure 27 Pathogen Growth
Figure 28 Other Organism Growth
Figure 29 Instruments Growth
Figure 30 Reagent Growth
Figure 31 Analysis Growth
Figure 32 Software & Other Growth
- 10x Genomics, Inc.
- 23andME Inc.
- Abbott Diagnostics
- AccuraGen Inc.
- Adaptive Biotechnologies
- Admera Health, LLC
- Agena Bioscience, Inc.
- Akonni Biosystems
- Ancestry.com LLC
- Anchor Dx
- ArcherDx, Inc.
- ARUP Laboratories
- Baylor Miraca Genetics Laboratories
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- BGI Genomics Co. Ltd
- Bioarray Genetics
- Biocept, Inc.
- Biodesix Inc.
- Biolidics Ltd
- bioMérieux Diagnostics
- Bioneer Corporation
- Bio-Rad Laboratories, Inc
- C2i Genomics
- Cancer Genetics
- Caris Molecular Diagnostics
- CellMax Life
- Chronix Biomedical
- Clear Labs
- Clinical Genomics
- Complete Genomics, Inc. - A BGI Company
- Dante Labs
- Datar Cancer Genetics Limited
- Day Zero Diagnostics
- Diasorin S.p.A.
- Epic Sciences
- Epigenomics AG.
- Eurofins Scientific
- Excellerate Bioscience
- Exosome Diagnostics
- Fabric Genomics
- Fluidigm Corp
- FUJIFILM Wako Diagnostics
- Fulgent Genetics
- GE Global Research
- GE Healthcare Life Sciences
- GeneFirst Ltd.
- Genetron Health (Beijing) Co., Ltd.
- Genomic Health
- Genomics England
- Genomics Personalized Health (GPH)
- Genzyme Corporation
- Grail, Inc.
- Guardant Health
- Horizon Discovery
- HTG Molecular Diagnostics
- Human Longevity, Inc.
- Incell Dx
- Invitae Corporation
- MDNA Life SCIENCES, Inc.
- MDx Health
- Meridian Bioscience
- Mesa Biotech
- miR Scientific
- MNG Labs
- Molecular MD
- NantHealth, Inc.
- Nebula Genomics
- New Oncology
- Novogene Bioinformatics Technology Co., Ltd.
- Omega Bioservices
- ORIG3N, Inc.
- Origene Technologies
- Oxford Nanopore Technologies
- Perkin Elmer
- Personal Genome Diagnostics
- Protagen Diagnostics
- Qiagen Gmbh
- Roche Molecular Diagnostics
- Roswell Biotechnologies
- Siemens Healthineers
- simfo GmbH
- Singlera Genomics Inc.
- Stratos Genomics
- Sure Genomics, Inc.
- Sysmex Inostics
- Tempus Labs, Inc.
- Thermo Fisher Scientific Inc.
- Veritas Genetics